SigmaGraft develops and manufactures next-generation biomaterials that support natural healing and improve patient outcomes.
Products backed by science and clinical evidence.
Continuous research and development for what's next.
Manufactured to the highest standards for patient safety.
Honoring the gift of donation and giving hope to patients.
Building strong relationships to deliver greater impact.
Our portfolio includes allograft and xenograft solutions that are safe, effective, and easy to use.
View All Products
Human donor-derived biomaterials that support natural tissue regeneration by providing a biologically compatible scaffold for healing.
Animal-derived biomaterials, typically processed from bovine or porcine sources, designed to provide long-lasting structural support for tissue regeneration.
Synthetic calcium phosphate-based biomaterials that closely resemble natural bone mineral to promote bone growth and integration.
Biologically derived materials, such as collagen, gelatin, or hyaluronic acid, that support cell attachment, tissue repair, and regenerative healing.
Our biomaterials are designed to support healing across a range of clinical applications.
Bone grafts and membranes for implant placement, ridge augmentation, and sinus lift procedures.
Learn More
Biomaterials for spinal fusion, trauma, and reconstructive orthopedic applications.
Learn More
Advanced matrices and membranes to support tissue regeneration and wound healing.
Learn More
Our biomaterials are designed to support healing across a range of clinical applications.
Bone grafts and membranes for implant placement, ridge augmentation, and sinus lift procedures.
Learn More
Biomaterials for spinal fusion, trauma, and reconstructive orthopedic applications.
Learn More
Advanced matrices and membranes to support tissue regeneration and wound healing.
Learn MoreWe invest in research, clinical studies, and advanced manufacturing to develop biomaterials that set new standards in regenerative medicine.
Learn MoreDeep expertise in tissue science and biomaterials.
Published results supporting safety and effectiveness.
Delivering trusted solutions to surgeons worldwide.
SigmaGraft is committed to the highest global standards to ensure product safety, quality, and traceability.
Our StandardsWe collaborate with surgeons, distributors, and healthcare partners to bring innovative solutions to more patients.
JOB INQUIRY
Submit your inquiry to info@sigmagraft.com about a job opportunity or submit your resume.
Elcin Chang is the Executive Vice President of SigmaGraft Biomaterials, where he oversees the research and development of next-generation biomaterials, the manufacture of high-quality medical devices, and the company’s private-label business segment.
Elcin Chang joined SigmaGraft in 2019, initially working in legal and regulatory affairs before becoming involved in nearly every aspect of the business, from research and development to manufacturing. He graduated from the University of San Diego with a degree in political science and joined the U.S. Army Reserve after college. He later earned both a law degree and an M.B.A. from the University of Maryland.
Outside of work, Elcin enjoys traveling and playing sports. He is deeply committed to his work, family, church, and community.